Literature DB >> 15341966

Synthesis of enantiomerically pure D-FDOC, an anti-HIV agent.

Shuli Mao1, Martin Bouygues, Christopher Welch, Mirlinda Biba, Jen Chilenski, Raymond F Schinazi, Dennis C Liotta.   

Abstract

The beta-D-enantiomer of FDOC (2',3'-dideoxy-5-fluoro-oxacytidine) exhibits potent anti-HIV-1 activity. It was obtained in optically pure form by employing a tandem kinetic resolution/chiral salt crystallization protocol. In addition, conditions were developed that allowed the unwanted butyrate ester of the L-enantiomer of FDOC to be racemized. This material could then be recycled in future resolutions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341966     DOI: 10.1016/j.bmcl.2004.07.016

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Pharmacology and pharmacokinetics of the antiviral agent beta-D-2',3'-dideoxy-3'-oxa-5-fluorocytidine in cells and rhesus monkeys.

Authors:  Brenda I Hernandez-Santiago; Huachun Chen; Ghazia Asif; Thierry Beltran; Shuli Mao; Selwyn J Hurwitz; Jason Grier; Harold M McClure; Chung K Chu; Dennis C Liotta; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

2.  Pharmacokinetics of the anti-human immunodeficiency virus agent 1-(beta-D-dioxolane)thymine in rhesus monkeys.

Authors:  Ghazia Asif; Selwyn J Hurwitz; Aleksandr Obikhod; David Delinsky; Janarthanan Narayanasamy; Chung K Chu; Harold M McClure; Raymond F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  2007-05-07       Impact factor: 5.191

Review 3.  Advance of structural modification of nucleosides scaffold.

Authors:  Xia Lin; Chunxian Liang; Lianjia Zou; Yanchun Yin; Jianyi Wang; Dandan Chen; Weisen Lan
Journal:  Eur J Med Chem       Date:  2021-01-30       Impact factor: 6.514

Review 4.  A Review of the Ongoing Research on Zika Virus Treatment.

Authors:  Suely da Silva; Daniel Oliveira Silva Martins; Ana Carolina Gomes Jardim
Journal:  Viruses       Date:  2018-05-14       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.